首页> 美国卫生研究院文献>BMC Complementary and Alternative Medicine >Protocol of a prospective study for the combination treatment of Shu-Gan-jian-Pi decoction and steroid standard therapy in autoimmune hepatitis patients
【2h】

Protocol of a prospective study for the combination treatment of Shu-Gan-jian-Pi decoction and steroid standard therapy in autoimmune hepatitis patients

机译:疏肝健脾汤联合类固醇激素标准疗法治疗自身免疫性肝炎的前瞻性研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPrednisone plus azathioprine is considered the mainstay of therapy in the current recommendations for autoimmune hepatitis (AIH). However, it does not provide good benefits for AIH patients because of its serious side effects. Therefore, more and more AIH patients prefer to seek for traditional Chinese medicine (TCM) to manage their symptoms and reduce the side effects of steroids in China. Shu-Gan-Jian-Pi Decoction is a popular used Chinese herbal formula in Guangdong province of China, which has demonstrated the effect of improving efficacy and reducing side effects of corticosteroids in AIH patients. The aim of this study is to evaluate the effects of Shu-Gan-Jian-Pi Decoction combined with steroid in AIH patients. So, this study aims to explore whether the combination treatment of Shu-Gan-Jian-Pi Decoction and steroid standard therapy could improve the clinical management of AIH.
机译:背景泼尼松加硫唑嘌呤被认为是当前针对自身免疫性肝炎(AIH)的推荐疗法的主要手段。但是,由于其严重的副作用,它不能为AIH患者提供良好的益处。因此,在中国,越来越多的AIH患者倾向于寻求中药(TCM)来治疗其症状并减少类固醇的副作用。舒肝健脾汤是中国广东省流行的中草药配方,已证明对改善AIH患者的糖皮质激素疗效和减轻其副作用。这项研究的目的是评估疏肝健脾汤联合类固醇对AIH患者的疗效。因此,本研究旨在探讨疏肝健脾汤联合类固醇激素标准疗法能否改善AIH的临床管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号